PMID- 36173970 OWN - NLM STAT- MEDLINE DCOM- 20230614 LR - 20230615 IS - 1502-7732 (Electronic) IS - 0300-9742 (Linking) VI - 52 IP - 4 DP - 2023 Jul TI - Impact of triage by a rheumatologist on appropriateness of referrals from primary to secondary care: a cluster randomized trial. PG - 403-411 LID - 10.1080/03009742.2022.2112833 [doi] AB - OBJECTIVE: The quality of referrals is often criticized, and the effectiveness of improvement efforts remains uncertain. We assessed the impact of a rheumatologist triaging patients in primary care on the appropriateness of referrals to secondary care, healthcare utilization, and patient experience and outcomes. METHOD: A cluster randomized controlled trial was conducted with patients experiencing musculoskeletal complaints. Intervention practices deployed an experienced rheumatologist triaging patients through in-person review. Usual care was performed in control practices, where practitioners referred patients based on their own judgement. The primary outcome was the proportion of inflammatory rheumatic diseases (IRDs) diagnosed by rheumatologists in referred patients. Healthcare utilization (iMTA Medical Consumption Questionnaire), quality of life (EuroQol 5 Dimensions), and experience of care (Consumer Quality Index) were determined after 3 months of follow-up. Data were analysed according to the intention-to-treat principle. RESULTS: In total, 544 participants were included [mean age 51.4 (range 18-87) years; 24% were men]. Of all referred patients, 51% had an IRD in the intervention group versus 21% in the control group (p = 0.035). After 3 months of follow-up, patients from the triage intervention showed lower healthcare utilization (p = 0.006) and higher quality of life (p = 0.011), without a decline in experienced quality of care (p = 0.712), compared to controls. CONCLUSION: Triage by a rheumatologist in primary care provides appropriate care and adequate experience of care, leading to a higher quality of life. Long-term evidence is needed to assess the value on cost-effectiveness before implementing this strategy nationwide. FAU - van Delft, Etam AU - van Delft E AUID- ORCID: 0000-0002-3744-1171 AD - Department of Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands. FAU - Lopes Barreto, D AU - Lopes Barreto D AUID- ORCID: 0000-0003-3143-4883 AD - Department of Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands. FAU - Han, K H AU - Han KH AD - Department of Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands. FAU - Tchetverikov, I AU - Tchetverikov I AUID- ORCID: 0000-0001-7870-8330 AD - Department of Rheumatology, Albert Schweitzer Hospital, Dordrecht, The Netherlands. FAU - Evertse, A AU - Evertse A AD - Medical Center Molenaar, Oud-Beijerland, The Netherlands. FAU - Kuijper, T M AU - Kuijper TM AUID- ORCID: 0000-0002-2834-5727 AD - Department of Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands. FAU - Hazes, Jmw AU - Hazes J AD - Department of Rheumatology, Erasmus Medical Center, Rotterdam, The Netherlands. FAU - Weel-Koenders, Aeam AU - Weel-Koenders A AUID- ORCID: 0000-0002-1831-5129 AD - Department of Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands. AD - Health Technology Assessment, Erasmus University, Rotterdam, The Netherlands. LA - eng PT - Journal Article PT - Randomized Controlled Trial DEP - 20220929 PL - England TA - Scand J Rheumatol JT - Scandinavian journal of rheumatology JID - 0321213 SB - IM MH - Male MH - Humans MH - Adolescent MH - Young Adult MH - Adult MH - Middle Aged MH - Aged MH - Aged, 80 and over MH - Female MH - *Secondary Care MH - *Rheumatologists MH - Triage MH - Quality of Life MH - Referral and Consultation MH - Cost-Benefit Analysis EDAT- 2022/09/30 06:00 MHDA- 2023/06/14 06:42 CRDT- 2022/09/29 15:04 PHST- 2023/06/14 06:42 [medline] PHST- 2022/09/30 06:00 [pubmed] PHST- 2022/09/29 15:04 [entrez] AID - 10.1080/03009742.2022.2112833 [doi] PST - ppublish SO - Scand J Rheumatol. 2023 Jul;52(4):403-411. doi: 10.1080/03009742.2022.2112833. Epub 2022 Sep 29.